Navigation Links
Oragene and Whole Genome Amplification with GenomiPhi

J. Chartier
DNA Genotek Inc., Ottawa, ON, Canada

DNA collected with Oragene is successfully amplified using the GenomiPhi DNA Amplification Kit and has the potential to generate near-unlimited quantities of DNA for downstream experiments.


Introduction
As the genotyping of single nucleotide polymorphisms (SNPs) becomes more automated and less costly, the limiting factor for genome-wide genetic analysis is becoming the limited amount of DNA that can be collected from study subjects. A renewable source of genomic DNA is desirable. The traditional method of transforming lymphoblastic cell lines is usually too expensive for population studies with large sample sizes. A less expensive alternative is whole genome amplification (WGA), which allows in vitro production of numerous copies of the entire genome.

Multiple displacement amplification (MDA) is a WGA method that uses Phi29 DNA polymerase and random priming. MDA generates high-fi delity genomic copies with minimal bias (ref. 1).

The GenomiPhi DNA Amplification Kit from Amersham Biosciences utilizes MDA to exponentially amplify genomic DNA. The purpose of this study was to determine if DNA collected with Oragene could be amplified with GenomiPhi and to test the quality of the amplified DNA for PCR and SNP genotyping.


Materials and Methods
DNA collection
Saliva was collected from 10 donors using Oragene DNA Self-Collection Kits. DNA was purified from 200 L aliquots of Oragene/saliva samples using the ethanol precipitation protocol supplied with the kits. Purifi ed DNA was redissolved in 200 L of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). DNA was quantified using a fluorimeter and SYBR Green I dye (Molecular Probes) according to the F/D Protocol (ref. 2).

Whole genome amplification
Following instructions provided with the GenomiPhi kit, 1 L of DNA was added to 9 L of sample buffer containing random hexamers and heated to 95C to denature the DNA. The sample was cooled and mixed with 9 L of reaction buffer containing salts and deoxynucleotides and 1 L of enzyme mix. The mixture was incubated overnight at 30C. After amplification, the Phi29 DNA polymerase was heat-inactivated during a 10 minute incubation at 65C. Table 1 summarizes the steps in the protocol.

The amplified DNA was quantified using the F/D Protocol. The molecular weight was analyzed by agarose gel electrophoresis with ethidium bromide staining and comparison with a Lambda-Hind III digest ladder.

Polymerase Chain Reaction
WGA and original unamplified DNA samples were analyzed by PCR and agarose gel electrophoresis for a 560 bp fragment of the human thymidylate synthetase gene.

SNP genotyping
A TaqMan SNP Genotyping Assay for the thymidylate synthetase (TYMS) gene was obtained from Applied Biosystems (TaqMan Assay ID: C___1637541_1_). WGA and original DNA samples were genotyped using a Rotor-Gene 3000 real-time quantitative thermal cycler (Corbett Research). Reactions were set up according to the manufacturers instructions (ref. 3, 4).


Results
Whole genome amplification
For the WGA reactions, the average amount of starting DNA template was 13 2 ng (mean SEM). The control DNA supplied with the kit had a concentration of 10 ng/L. The average amount of DNA after amplification was 7.60 0.13 g, representing about a 600-fold increase. Figure 1 compares the molecular weight of WGA and unamplified DNA samples.

Polymerase Chain Reaction
Figure 2 shows a typical PCR result for WGA and unamplified DNA samples.

SNP genotyping
Figure 3 shows an allelic discrimination plot for the thymidylate synthetase assay. The plot is presented as the signal (average fluorescence between cycles 41 and 45) minus the background (average fluorescence between cycles 21 and 25).


Discussion and Conclusions
According to the manufacturer, 10 ng of starting DNA should generate 4 to 7 g of amplified DNA with a high molecular weight (ref. 5). DNA from Oragene was successfully amplified with the GenomiPhi kit and gave an average yield of 7.60 g, slightly higher than the expected amount. The amplified DNA worked well for both PCR and TaqMan reactions. The WGA DNA gave similar PCR bands to the original unamplified DNA and the SNP genotyping calls were identical.

With Oragene, the median DNA yield is 110 g from 2 mL of saliva (ref. 6). GenomiPhi allows DNA from Oragene to be amplified around 600-fold. Furthermore, this amplified DNA may be used as the template for subsequent WGA reactions. Up to 4 re-amplifications have been performed with no apparent effect on PCR of various loci across the human genome (ref. 7). In summary, DNA collected with Oragene works well with the GenomiPhi WGA kit and has the potential to generate near-unlimited quantities of DNA for downstream experiments.


References
1. Lasken, R. & Egholm, M. (2003). Whole gen ome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotech. 21(12): 531-535.

2. Technical Bulletin: DNA Quantification Using the Fluorescence/DNase (F/D) Assay, v1.2. DNA Genotek. Nov 29, 2004.

3. TaqMan SNP Genotyping Assays Protocol. Part Number 4332856 Rev. B. Applied Biosystems. June, 2004.

4. Technical Bulletin: Oragene is compatible with TaqMan SNP genotyping, v1.0. DNA Genotek. Jan, 2005.

5. GenomiPhi DNA Amplification Kit Instructions. 74004229 Ed. AB. Amersham Biosciences. 2003.

6. Technical Bulletin: DNA Yield with Oragene, v1.5. DNA Genotek. Sept, 2004.

7. GenomiPhi FAQ and Troubleshooting. http://www4.amershambiosciences. com/aptrix/upp01077.nsf/Content/autodna_genomiphi_faqs#Use (checked February 2, 2005)


back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. DNA Stability with Oragene
2. DNA Yield with Oragene
3. Oragene and DNA sequencing with ABI PRISM
4. Oragene is compatible with TaqMan SNP genotyping
5. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
6. Protocol for GenomePlex Whole Genome Amplification from Buccal Swab
7. Protocol for GenomePlex Whole Genome Amplification from Blood Card
8. Protocol for GenomePlex Whole Genome Amplification from Plant
9. Protocol for GenomePlex Whole Genome Amplification from Soil
10. Protocol for GenomePlex Whole Genome Amplification from Whole Blood
11. Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):